For Immediate Release
Ft. Lauderdale, Sept. 30 - 1999

Emerging Medical Technologies East Conference
Oct. 4-5, 1999 (www.medicaldata.com) Reston, Virginia

Howard J. Leonhardt, CEO of Bioheart, Inc. will present elements of their business plan at the upcoming EMT conference. Bioheart, Inc. is focused on delivery of customized cardiovascular therapies based on genotyping (bioheartinc.com)

Bioheart, Inc. through its Bioheart Health Plans Division, and investments in Bioheart Genotyping, Inc., Bioheart MicroImplants, Inc. and Stem Cell Labs, Inc. utilizes the latest advances in genetic engineering to deliver CUSTOMIZED CARE to prevent and treat cardiovascular and heart disease.

1. Matching the right therapy and diet to the right patient utilizing genetic mapping (genotyping).

2. Repairing the heart and blood vessels utilizing targeted cellular based tissue engineering, patient specific utilizing an individual's own DNA to avoid immune system rejection.

3. Services and OTC products related to preventing cardiovascular and heart disease - THE BIOHEART PLAN and BIOHEART ADVANCED PLAN.

We intend to be a partner to prevent and treat cardiovascular and heart disease from birth until the last years of life. At birth we will collect and store cord blood and placenta that will be used later in life for cellular based tissue engineering repair with your own DNA. During youth we will promote a heart healthy lifestyle - diet (patient specific based on genotype) including nutritional supplements, exercise and stress reduction in partnership with existing firms specializing in these areas. During the middle ages we will aggressively apply genotyping to map out the best strategy of risk reduction for our members. During the advanced ages we will make available to our members the most advanced therapies for treating cardiovascular and heart disease driven by advances in cellular based tissue engineering.

We believe our services will engage patients in a manner more intimate and close than ever before. We will be a true partner in reducing the risk of death from cardiovascular and heart disease. The Bioheart Advanced Plan offered by Bioheart Health Plans Division of Bioheart, Inc. includes a visit to the member's home by a nutritionist. Genetic information will be used to match the right diet and therapies with the right person. A 1-800 line and internet home page will provide access to diet and exercise consultants and a referral service to physician services. Bioheart will offer complementary OTC products such as aspirin, nutritional supplements and fitness videos, memberships through a catalog.

Realizing the incredible potential of embryonic stem cells, the master cells of tissue development which can be differentiated to become nearly any other type of cell needed for life including cardiomyocytes (heart muscle cells), we have formed a subsidiary Stem Cell Labs, Inc. to focus on embryonic stem cell applications and production.

For patients with failing hearts, Bioheart Microimplants, Inc. is currently focused on research to regenerate heart muscle and to stimulate angiogenesis (new blood vessels to feed the muscle) and cardiac function with the injection of a plug comprised of embryonic stem cells (differentiated to become cardiomyocytes) with genes expressing various proteins, enzymes and growth factors into the myocardium (heart muscle) utilizing a catheter based technique incorporating our proprietary micro implant technologies (U.S. Patent 5,878,751 & 5,591,159 exclusive options) . This myocardial implant will be encoded with a patient's own DNA to avoid rejection.

TOP OF PAGE | RETURN TO INDEX

Contact Information: